The authors propose that MFN2 S200 phosphorylation in cancer tissues increases MFN2/Pyruvate kinase isoform 2 (PKM2) interaction, thereby favoring mitochondrial fusion and the switch between OXPHOS and glycolysis. This evidence concerns the gene MFN2 and cancer.